Trutino Biosciences - Ownership and Business Overview

Life ScienceCompany

Trutino Biosciences Ownership

Who owns Trutino Biosciences?

Trutino Biosciences is owned by Boehringer Ingelheim. It was acquired on June 14, 2022.

Trutino Biosciences Business Overview

Where is Trutino Biosciences headquartered?

Trutino Biosciences is headquartered in San Diego, California.

What sector is Trutino Biosciences in?

Trutino Biosciences is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 291 acquisitions of life science companies in 2022, including 36 acquisitions by private equity firms, and 255 by strategics.

Trutino Biosciences

Trutino Biosciences, Inc.

10179 Huennekens St, Suite 101,
San Diego, California 92121
United States,
(310) 218-7553
www.trutinobio.com

Trutino Biosciences is a research-driven biopharmaceutical company with a mission to restore immune balance in cancer patients by developing the next generation cytokine therapies that can safely activate tumor-fighting immune cells at the disease site without causing adverse side effects. Trutino Biosciences is based in San Diego, California.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.